Elizabeth Murphy Fitelson, MD

Laurel Mayer, M.D. is Associate Professor of Clinical Psychiatry at the Columbia University College of Physicians and Surgeons. She received a BA at Yale University and her MD degree at the Albert Einstein College of Medicine. Dr. Mayer's research interest currently focuses on using sophisticated eating behavior paradigms to evaluate eating behavior across the eating and weight disordered spectrum. Building on successful studies of eating behavior in anorexia nervosa, Dr. Mayer is currently exploring (1) the potential influence of the FTO gene on eating behavior and fronto-striatal brain circuits in healthy, normal weight kids, in order to potentially identify risk factors for later weight gain. (2) the potential biological correlates of weight suppression (the difference between one’s lifetime and current weight) in women with bulimia nervosa in order to test the hypothesis that higher levels of weight suppression and currently being on a diet to lose weight, will be independently associated with lower resting metabolic rate and lower levels of metabolic (e.g. thyroid), reproductive (e.g., estrogen) and appetitive (e.g., leptin) hormone levels among women with bulimia nervosa. (3) the utility of short-term residential laboratory-based measures in predicting the longer-term effects of pharmacologic agents in promoting weight loss. (4) measuring the influence of dietary macronutrients distributions (e.g. low carb compared to standard American) on intake and energy expenditure and (5) evaluating the weight gain and related metabolic side effects of second-generation antipsychotics.

Frances Rudnick Levin, MD is the Kennedy-Leavy Professor of Psychiatry at Columbia University and the Chief of the Division on Substance Use Disorders at NYSPI/Columbia University. For over twenty years, she served as the Director of the Addiction Psychiatry Fellowship Program at New York-Presbyterian Hospital and for the past sixteen years, she has been the PI of a T32 NIDA funded Substance Abuse Research Fellowship which has been continuously funded since 1994. Dr. Levin graduated from Cornell University Medical College and completed her psychiatric residency at the New York Hospital-Payne Whitney Clinic. Subsequently, she graduated from a 2-year combined clinical and research fellowship at the University of Maryland and the Addiction Research Center, the intramural branch of the National Institute on Drug Abuse (NIDA). Currently, she serves as the Medical Director of the Providers’ Clinical Support System (PCSS), a SAMHSA-supported national training and mentoring initiative focused on addressing the opioid use disorder crisis. Also, she is the Medical Director of a SAMHSA-supported State Targeted Response technical assistance grant (the Opioid Response Network) to address the national opioid epidemic. Dr. Levin, working with other senior faculty, inaugurated the university-wide Center for Healing of Opioid and Other Substance Use Disorders: Enhancing Intervention Development and Implementation (CHOSEN) in 2020 and serves as one of the senior Directors. Moreover, she is the principal investigator of several federal grants, including a K24 Mid-Career Investigator Award as well as a Co-Investigator on numerous other grants. Her current research interests include pharmacologic and psychotherapeutic treatment interventions for opioid, cocaine and marijuana use disorders, and treatment approaches for adults with substance use disorders and attention-deficit hyperactivity disorder along with other psychiatric illnesses. Dr. Levin has over two-hundred and fifty articles and book chapters on a wide range of topics including treatments of substance use disorders, assessment, and treatment of co-occurring psychiatric illnesses and vulnerabilities associated with substance use disorders. She has served on several advisory panels and ad-hoc federal grant review groups and was a member of the NIDA – Initial Review Group: Training and Career Development Subcommittee for eight years and served as a member to the NIDA Interventions to Prevent and Treat Addiction (IPTA). She is currently on the Board of Directors for the American Academy of Addiction Psychiatry (AAAP), the College on Drug Dependence (CPDD), and the American Society of ADHD and Related Disorders (APSARD). She is an editorial board member of three journals, past President of the American Academy of Addiction Psychiatry, and past Chair of the APA Council on Addiction Psychiatry.

Dr. Zuckerman joined the Columbia faculty as assistant clinical professor of pediatrics in July of 2011 after spending seven years as a pediatrics resident and pediatric cardiology fellow at Columbia University Medical Center. In 2009, Dr. Zuckerman was chosen as one of the chief fellows in the division of pediatric cardiology. His research interests include pediatric cardiomyopathies, donor- and recipient-related issues surrounding pediatric heart transplantation, and drug therapies for prevention and treatment of graft rejection following heart transplantation. He is part of the faculty with the Program for Pediatric Cardiomyopathy, Heart Failure, and Transplantation, and was named associate director of the fellowship in the division of pediatric cardiology in July of 2015.